Down-regulation of SOCS3 expression by methylation correlates with lymph node metastases of NSCLCs

Chinese Journal of Lung Cancer

Volumn 11, Issue 2, 2008, Pages 220-225

  Zhang, Siyang ^a   Zhang, Qingfu ^a   Gu, Yumei ^a   Wang, Enhua ^a   Qiu, Xueshan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Expression; Lung neoplasms; Metastasis; Methylation; SOCS3

Indexed keywords

SUPPRESSOR OF CYTOKINE SIGNALING 3;

ARTICLE; CANCER PATIENT; CANCER STAGING; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GENE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METHYLATION; OPTICAL DENSITY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN METABOLISM; STATISTICAL SIGNIFICANCE; SUPPRESSOR OF CYTOKINE SIGNALING 3 GENE; TISSUE SECTION; WESTERN BLOTTING;

EID: 43649091266     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2008.02.008     Document Type: Article

References (15)

1. Rigby RJ, Simmons JG, Greenhalgy CJ, et al. Suppressor of cytokine signaling 3(SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon. Oncogene, 2007, 26(33): 4833-4841.
2. Sutherland KD, Vaillant F, Alexander WS, et al. c-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3. EMBO J, 2006, 25(24): 5805-5815.
3. Ogata H, Kobayashi T, Chinen T, et al. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology, 2006, 131(1): 179-193.
4. Niwa Y, Kanda H, Shikauchi Y, et al. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Oncogene, 2005, 24(42): 6406-6417.
5. Weber A, Hengge UR, Bardenheuer W, et al. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene, 2005, 24(44): 6699-6708.
6. Tokita T, Maesawa C, Kimura T, et al. Methylation status of the SOCS3 gene in human malignant melanomas. Int J Oncol, 2007, 30(3): 689-694.
7. Tischoff I, Hengge UR, Vieth M, et al. Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma. Gut, 2007, 56(8): 1047-1053.
8. Bellezza I, Neuwirt H, Nemes C, et al. Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer. Am J Pathol, 2006, 169(6): 2199-2208.
9. Evans MK, Yu CR, Lohani A, et al. Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals. Oncogene, 2007, 26(13): 1941-1948.
10. Komyod W, Böhm M, Metze D, et al. Constitutive suppressor of cytokine signaling 3 expression confers a growth advantage to a human melanoma cell line. Mol Cancer Res, 2007, 5(3): 271-281.
11. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 1996, 93(18): 9821-9826.
12. Nagai H, Tokumaru S, Sayama K, et al. Suppressor of cytokine signaling 3 negative regulation of signal transducer and activator of transcription 3 in platelet-derived growth factor-induced fibroblast migration. J Dermatol, 2007, 34(8): 523-530.
13. Krishnadasan R, Bifulco C, Kim J, et al. Overexpression of SOCS3 is associated with decreased survival in a cohort of patients with de novo follicular lymphoma. Br J Haematol, 2006, 135(1): 72-75.
14. He B, You L, Uematsu K, et al. SOCS-3 is frequently silenced by hypermethylation and suppress cell growth in human lung cancer. Proc Natl Acad Sci USA, 2003, 100(24): 14133-14138.
15. Tokumaru S, Sayama K, Yamasaki K, et al. SOCS3/CIS3 negative regulation of STAT3 in HGF-induced keratinocyte migration. Biochem Biophys Res Commun, 2005, 327(1): 100-105.